| next >> |
| Start date | Project | acronym | role | funding | partners |
|---|
| 2023-01-01 | Doctoral network for microprocess engineering for electrosynthesis - new synthesis concepts for pharmaceutical/ fine chemical industry |
MiEL | participant | 2.660.962 | 14 |
| 2022-09-01 | CREATING FRAMEWORK CONDITIONS FOR RESEARCH MANAGEMENT TO STRENGTHEN THE EUROPEAN RESEARCH AREA |
RM ROADMAP | participant | 1.499.997 | 8 |
| 2022-09-01 | How to minimize the ecological footprint for functional electronics? |
ECOTRON | participant | 4.999.000 | 11 |
| 2021-11-01 | European platform for neurodegenerative disorders |
EPND | participant | 9.680.000 | 29 |
| 2021-11-01 | Preparing for RSV Immunisation and Surveillance in Europe |
PROMISE | participant | 3.744.375 | 22 |
| 2021-09-01 | BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe |
BEAMER | participant | 5.948.903 | 31 |
| 2021-09-01 | Allostery in Drug Discovery |
ALLODD | participant | 3.669.354 | 13 |
| 2021-06-01 | ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS |
UNITE4TB | participant | 92.500.000 | 32 |
| 2021-06-01 | Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders |
REALMENT | participant | 6.000.000 | 15 |
| 2021-02-01 | Central Repository for Digital Pathology |
BIGPICTURE | participant | 32.319.825 | 51 |
| 2021-01-01 | Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy |
T2EVOLVE | participant | 8.728.185 | 29 |
| 2021-01-01 | A fully integrated, animal-free, end-to-end modelling approach to oral drug product development |
InPharma | participant | 3.464.964 | 11 |
| 2021-01-01 | Advanced machine learning for Innovative Drug Discovery |
AIDD | participant | 3.926.573 | 17 |
| 2021-01-01 | Boosting advanced doctoral training in innovative colon targeting drugs |
COLOTAN | participant | 3.533.108 | 10 |
| 2021-01-01 | Drug repurposing and discovery multidisciplinary training network |
DRUGtrain | participant | 2.394.817 | 8 |
| 2020-11-01 | Accelerating Research & Development for Advanced Therapies |
ARDAT | participant | 11.773.000 | 34 |
| 2020-05-01 | Process Analytical Technology Tools for Real-Time Physical and Chemical Characterization of Nanosuspensions |
PAT4Nano | participant | 5.092.409 | 10 |
| 2020-04-01 | Corona Accelerated R&D in Europe |
CARE | participant | 36.559.186 | 43 |
| 2020-04-01 | Swift COronavirus therapeutics REsponse |
SCORE | participant | 2.576.063 | 10 |
| 2020-01-01 | PharmaLedger |
PharmaLedger | participant | 8.290.694 | 30 |
| 2020-01-01 | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS |
ERA4TB | participant | 89.815.600 | 33 |
| 2019-11-01 | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases |
IDEA-FAST | participant | 20.997.523 | 47 |
| 2019-11-01 | EU Patient- cEntric clinicAl tRial pLatform |
EU-PEARL | participant | 12.004.953 | 37 |
| 2019-11-01 | Collaboration for Prevention and Treatment of MDR Bacterial Infections |
COMBINE | participant | 8.000.000 | 11 |
| 2019-10-01 | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies |
Immune-Image | participant | 15.000.000 | 23 |
| 2019-10-01 | Long Acting Medicines for Complex Therapeutics Needed Now |
LongActNow | participant | 1.292.901 | 3 |
| 2019-10-01 | A Centre of Excellence in Computational Biomedicine |
CompBioMed2 | participant | 7.992.823 | 16 |
| 2019-09-01 | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions |
3TR | participant | 40.273.192 | 70 |
| 2019-09-01 | Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials |
Trials@Home | participant | 19.036.998 | 33 |
| 2019-06-01 | MachinE Learning Ledger Orchestration for Drug DiscoverY |
MELLODDY | participant | 8.000.000 | 17 |
| 2019-05-01 | Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs |
RespiriNTM | participant | 5.687.984 | 9 |
| 2019-05-01 | Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors |
RespiriTB | participant | 6.840.000 | 9 |
| 2019-04-01 | Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation |
ConcePTION | participant | 15.299.991 | 53 |
| 2019-04-01 | The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use |
VALUE-Dx | participant | 6.799.100 | 26 |
| 2019-03-01 | EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells |
EBiSC2 | participant | 4.599.648 | 18 |
| 2019-03-01 | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts |
IMMUcan | participant | 17.830.000 | 28 |
| 2019-03-01 | Efficiently Networking European Neurodegeneration Research |
NEURONET | participant | 1.199.125 | 10 |
| 2019-02-01 | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease |
TransBioLine | participant | 13.999.998 | 29 |
| 2019-01-01 | FAIRplus |
FAIRplus | participant | 3.996.150 | 22 |
| 2019-01-01 | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain |
IM2PACT | participant | 9.000.000 | 27 |
| 2019-01-01 | Remote Assessment of Disease and Relapse – Alzheimer’s Disease |
RADAR-AD | participant | 4.999.757 | 17 |
| 2019-01-01 | Multiscale Analysis of Thermomechanical Behaviour of Granular Materials |
MatheGram | participant | 4.170.178 | 15 |
| 2018-12-01 | European Screening Centre; Unique Library for Attractive Biology |
ESCulab | participant | 18.249.993 | 20 |
| 2018-11-01 | European Health Data and Evidence Network |
EHDEN | participant | 14.105.750 | 22 |
| 2018-11-01 | Artificial Intelligence to transform Drug and Chemical safety testing |
PATH-TOX | coordinator | 2.054.499 | 3 |
| 2018-06-01 | Autism Innovative Medicine Studies – 2 – Trials |
AIMS-2-TRIALS | participant | 54.999.999 | 48 |
| 2018-05-01 | conect4children (COllaborative Network for European Clinical Trials For Children) |
c4c | participant | 67.000.000 | 47 |
| 2018-05-01 | Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope |
PIONEER | participant | 6.000.000 | 34 |
| 2018-03-01 | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. |
PARADIGM | participant | 4.498.931 | 35 |
| 2017-10-01 | Memory research: Ground-breaking, Applied, and Technological Exchanges |
M-GATE | participant | 3.961.160 | 11 |
| next >> |
